Synergy Innovation Co., Ltd. — Investor Relations & Filings
Synergy Innovation Co., Ltd. is a company focused on the biotechnology sector, which it considers a primary growth engine. The company engages in research, development, and investment activities related to new and generic drugs, medical devices, and health functional foods. Its R&D efforts encompass areas such as genetics and the development of cell culture mediums. Synergy Innovation actively pursues growth through a combination of internal projects and strategic external investments to expand its portfolio.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 소속부변경 | 2026-04-30 | Korean | |
| 전환가액의조정 | 2026-04-22 | Korean | |
| [기재정정]주요사항보고서(타법인주식및출자증권양도결정) | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-27 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-03-23 | Korean | |
| 사업보고서 (2025.12) | 2026-03-19 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 39069603 | 소속부변경 | 2026-04-30 | Korean | ||
| 35185931 | 전환가액의조정 | 2026-04-22 | Korean | ||
| 33124018 | [기재정정]주요사항보고서(타법인주식및출자증권양도결정) | 2026-04-01 | Korean | ||
| 33057962 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33010914 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-03-23 | Korean | ||
| 32985389 | 사업보고서 (2025.12) | 2026-03-19 | Korean | ||
| 32982833 | 감사보고서제출 | 2026-03-19 | Korean | ||
| 32968953 | [기재정정]주요사항보고서(타법인주식및출자증권양도결정) | 2026-03-18 | Korean | ||
| 32935738 | 주주총회소집공고 | 2026-03-12 | Korean | ||
| 32935144 | 주주총회집중일개최사유신고 | 2026-03-12 | Korean | ||
| 32934923 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2026-03-12 | Korean | ||
| 32934922 | 주주총회소집결의 | 2026-03-12 | Korean | ||
|
2025
3 filings
| |||||
| 12202335 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2025-12-22 | Korean | ||
| 33019995 | [기재정정]주요사항보고서(타법인주식및출자증권양도결정) | 2025-09-25 | Korean | ||
| 33019174 | 전환가액의조정 | 2025-09-22 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Synergy Innovation Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17341/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17341 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17341 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17341 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17341}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Synergy Innovation Co., Ltd. (id: 17341)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.